Trial Profile
Kinetics of Integrilin Limited by Obesity (KILO): A Multi-Center Randomized Clinical Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jan 2012
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary)
- Indications Coronary disorders
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms KILO
- 01 Dec 2011 Results published in the American Heart Journal.
- 03 May 2011 New trial record
- 05 Apr 2011 Results presented at the 60th Annual Scientific Session of the American College of Cardiology.